| CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
| MIR3936HG |
|
MIR3936 host gene
|
|
|
0.861 |
0.269 |
| CCDC162P |
|
coiled-coil domain containing 162, pseudogene
|
|
|
0.890 |
0.154 |
| CADM3-AS1 |
|
CADM3 antisense RNA 1
|
|
|
1.000 |
0.038 |
| LINC01478 |
|
long intergenic non-protein coding RNA 1478
|
|
|
1.000 |
0.077 |
| SEC1P |
|
secretory blood group 1, pseudogene
|
|
|
0.792 |
0.385 |
| MIR29B2CHG |
|
MIR29B2 and MIR29C host gene
|
|
|
0.839 |
0.192 |
| JAZF1-AS1 |
|
JAZF1 antisense RNA 1
|
|
|
1.000 |
0.115 |
| LINC02652 |
|
long intergenic non-protein coding RNA 2652
|
|
|
1.000 |
0.115 |
| KIF9-AS1 |
|
KIF9 antisense RNA 1
|
|
|
1.000 |
0.077 |
| MYO1G |
B0I1T2
|
myosin IG
|
Cellular structure
|
4.4E-10 |
0.861 |
0.231 |
| KRBOX1 |
C9JBD0
|
KRAB box domain containing 1
|
|
1.8E-02 |
1.000 |
0.077 |
| ACKR2 |
O00590
|
atypical chemokine receptor 2
|
G-protein coupled receptor
|
1.4E-03 |
0.641 |
0.615 |
| TNFRSF10C |
O14798
|
TNF receptor superfamily member 10c
|
|
3.2E-06 |
0.578 |
0.731 |
| AZIN1 |
O14977
|
antizyme inhibitor 1
|
Enzyme
|
0.99 |
0.716 |
0.462 |
| NPC1 |
O15118
|
NPC intracellular cholesterol transporter 1
|
Transporter
|
6.5E-06 |
0.518 |
0.692 |
| RAD51B |
O15315
|
RAD51 paralog B
|
|
2.1E-15 |
0.556 |
0.769 |
| FADS1 |
O60427
|
fatty acid desaturase 1
|
|
0.37 |
0.582 |
0.769 |
| CA11 |
O75493
|
carbonic anhydrase 11
|
|
9.6E-04 |
0.674 |
0.385 |
| S1PR2 |
O95136
|
sphingosine-1-phosphate receptor 2
|
G-protein coupled receptor
|
1.8E-02 |
0.585 |
0.731 |
| TBC1D8 |
O95759
|
TBC1 domain family member 8
|
Enzyme
|
5.6E-13 |
0.760 |
0.346 |
| FADS2 |
O95864
|
fatty acid desaturase 2
|
|
1.00 |
0.575 |
0.692 |
| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
| GC |
P02774
|
GC vitamin D binding protein
|
Transporter
|
2.7E-11 |
0.489 |
0.885 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |